Single-inhaler ICS-LABA-LAMA combinations approved for asthma treatment (details)

Active ingredients	Brand names (Type)	Strength (microg)*	Dose	Age	PBS code	PBS streamlined authority code	Maximum quantity (5 repeats for all)	Actuations per device
Beclometasone Formoterol Glycopyrronium	Trimbow (pMDI)	100/6/10	2 inhalations twice daily	≥ 18 years	14606R	12603	1	120
Beclometasone Formoterol Glycopyrronium	Trimbow (pMDI)	200/6/10	2 inhalations twice daily	≥ 18 years	13200R	12603	1	120
Fluticasone furoate Vilanterol Umeclidinium	Trelegy Ellipta (DPI)	200/25/62.5	1 inhalation once daily	≥ 18 years	12917W	12603	1	30
Fluticasone furoate Vilanterol Umeclidinium	Trelegy Ellipta (DPI)	200/25/62.5	1 inhalation once daily	≥ 18 years	14382Y^†	15601	2	30
Mometasone Indacaterol Glycopyrronium	Enerzair Breezhaler (DPI)	68/114/46	2 inhalations per capsule once daily	≥ 18 years	12298G	12603	1	30
		68/114/46	2 inhalations per capsule once daily	≥ 18 years	14471P^†	15601	2
		136/114/46	2 inhalations per capsule once daily	≥ 18 years	12295D	12603	1
		136/114/46	2 inhalations per capsule once daily	≥ 18 years	14399W^†	15601	2

Additional information

DPI: dry powder inhaler; ICS: inhaled corticosteroid; LABA: long-acting beta₂ agonist; LAMA: long-acting muscarinic antagonist; pMDI: pressurised metered-dose inhaler

*ICS dose/LABA dose/LAMA dose

† The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient (60-day prescribing)